
Pharma
“Medicine is the restoration of discordant elements; sickness is the discord of the elements infused into the living body.” - Leonardo da Vinci
Navigating the New Frontier: The First Abridged Complaint under the 2024 ABPI Code
In the ever-evolving landscape of pharmaceutical marketing, the industry faces a delicate balance between informing the public and adhering to strict regulations. This challenge was thrust into the spotlight with the recent case of CSL Seqirus and the alleged promotion of their prescription-only Flucelvax Influenza vaccine on the social media platform LinkedIn.
Antibodies Revolutionizing Cancer Care: Past Successes and Future Promise
Antibody-based therapies have transformed cancer treatment over the past few decades. A recent review published in Nature Reviews Cancer provides a comprehensive overview of the progress made to date and the exciting new frontiers on the horizon
Why Are Medical Staff Liasions’s Interactions Different?
The ruling on this PMCPA case from December 2023 raises several discussions points around providing clarity for medical liaison staff and their interactions at conferences
Ensuring Accuracy of Prescribing Information in Today’s Digital Landscape
This case illuminates pharmaceutical companies' indispensable duty to diligently oversee processes updating drug learning and prescribing materials as product knowledge progresses.
AI | MHRA – Harnessing New Technology While Ensuring Public Safety?
While AI promises major benefits like faster treatment, more personalized care, and improved access to treatment, it also risks introducing new challenges if not properly governed. The Medicines and Healthcare products Regulatory Agency (MHRA) faces the complex task of enabling innovation while protecting patients
AI | Artificial Intelligence and the Future of Healthcare – EFPIA
The European Federation of Pharmaceutical Industries and Associations (EFPIA) outlines their vision for maximizing the benefits of AI while ensuring patient safety and privacy. This postion paper is for consideration by legislators and regulators of the emerging AI frameworks.
Lessons for Pharma from a Pre-Approval Social Media Misstep
One ill-advised retweet over two years ago regarding data for an unapproved product has resulted in significant learnings for Pfizer and the pharmaceutical industry about the careful boundaries of using social media
GlaxoSmithKline Files Lawsuit Against Pfizer-BioNTech Over COVID-19 Vaccine Technology
Pharmaceutical giant GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer-BioNTech, claiming patent infringement related to the technology used in their highly successful COVID-19 vaccine. This legal battle is expected to have far-reaching implications for the future of vaccine development.
Cracking the Code of Bitter Taste Receptors
Our sense of taste plays an important role in keeping us healthy. New research is providing unprecedented insights into how one of the body's primary bitter taste receptors functions at the molecular level
Unraveling the Mechanisms Behind Resistance to Novel Cancer Therapies
Scientists uncover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers
Guiding Pharma Through the Complexities of Social Media
This article seeks to distil the most important principles from the recently updated 'PMCPA Social Media Guidance 2023' document for pharmaceutical companies operating in the UK

- Millions of new solar system objects to be found...on June, 2025 at 1:34 am
Astronomers have revealed new research showing that millions of new solar system objects are likely to be detected by a brand-new facility, which is expected to come online later this year.
- Collaboration can unlock Australia's energy...on June, 2025 at 9:29 pm
New research demonstrates that with collaboration between stakeholders, Australia can fully decarbonize its domestic and energy export economies by 2060 -- a feat requiring $6.2 trillion USD and around 110,000 square kilomters of land -- while avoiding harm to important areas for biodiversity […]
- Guardrails, education urged to protect adolescent...on June, 2025 at 6:12 pm
The effects of artificial intelligence on adolescents are nuanced and complex, according to a new report that calls on developers to prioritize features that protect young people from exploitation, manipulation and the erosion of real-world relationships.
- Molecular link between air pollution and...on June, 2025 at 6:12 pm
A new study found exposure to specific tiny particles in air pollution during pregnancy are associated with increased risk of various negative birth outcomes.
- Atmospheric chemistry keeps pollutants in the airon June, 2025 at 3:50 pm
A new study details processes that keep pollutants aloft despite a drop in emissions.
After 11 years, Boston Dynamics has said goodbye to its humanoid robot ATLAS HD. The robotics company says it’s time for ATLAS to “kick back and relax” in retirement, letting the new all electric ATLAS take over. This video was shared to remember ATLAS HD’s great moments and those not so great.
Header Banner: AZT the development name for zidovudine was the first drug launched to treat HIV. It was used in high doses and as monotherapy, causing horrendous side effects and resistance in the HIV virus. In the subsequent 30 years clinical trials has led to the development of single tablet, once daily regimens to treat HIV with limited side effects. Now a two pill combination called Truvada can be given to individuals to prevent the risk of acquiring HIV (shown in the DarkDrug logo).